• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌中3号染色体短臂、5号染色体长臂和17号染色体短臂的等位基因缺失。

Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.

作者信息

Sugimura J, Tamura G, Suzuki Y, Fujioka T

机构信息

Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan.

出版信息

Pathol Int. 1997 Feb-Mar;47(2-3):79-83. doi: 10.1111/j.1440-1827.1997.tb03724.x.

DOI:10.1111/j.1440-1827.1997.tb03724.x
PMID:9088024
Abstract

Loss-of-heterozygosity (LOH) has been studied on 3p (von Hippel-Lindau gene locus), 5q and 17p (p53 gene locus) by a polymerase chain reaction (PCR)-based strategy in 42 sporadic renal cell carcinomas (RCC). LOH at seven microsatellite loci on 5q was investigated because a tumor suppressor gene on 5q involved in the development and/or progression of RCC has not yet been identified. LOH was found in seven (17%) RCC at single or multiple loci on 5q, 38% (11/29 informative cases) on 3p, and 6% (2/35 informative cases) on 17p. Replication error (RER) was present in 10% (4/42) RCC at single or multiple loci. The minimum region of deletion on 5q to account for LOH was mapped to 5q31.1 (interferon regulatory factor-1; IRF-1 locus), where LOH was detected in 23% (6/26 informative cases). LOH on 3p and 5q occurred in both stage 2 and more advanced (stage 3 and 4) tumors at similar incidences (41 and 33% on 3p; and 24 and 22% on 5q, respectively), suggesting that LOH on these chromosomes is an early genetic event. All RCC exhibiting LOH on 3p or 5q (IRF-1 locus) were the clear cell or the mixed clear and granular cell types. These findings suggest that LOH on 3p and 5q plays an important role in the genesis of clear cell RCC. In addition, only one tumor exhibited LOH on both 3p and 5q, which suggests that LOH occurs not sequentially but independently.

摘要

采用基于聚合酶链反应(PCR)的方法,对42例散发性肾细胞癌(RCC)的3p(冯希佩尔-林道基因位点)、5q和17p(p53基因位点)进行杂合性缺失(LOH)研究。对5q上7个微卫星位点的LOH进行了研究,因为5q上一个参与RCC发生和/或进展的肿瘤抑制基因尚未被鉴定。在5q的单个或多个位点上,7例(17%)RCC中发现了LOH,3p上为38%(11/29例信息性病例),17p上为6%(2/35例信息性病例)。10%(4/42)的RCC在单个或多个位点存在复制错误(RER)。5q上导致LOH的最小缺失区域定位于5q31.1(干扰素调节因子-1;IRF-1位点),在23%(6/26例信息性病例)中检测到LOH。3p和5q上的LOH在2期及更晚期(3期和4期)肿瘤中的发生率相似(3p上分别为41%和33%;5q上分别为24%和22%),这表明这些染色体上的LOH是早期遗传事件。所有在3p或5q(IRF-1位点)表现出LOH的RCC均为透明细胞型或透明细胞与颗粒细胞混合型。这些发现表明,3p和5q上的LOH在透明细胞RCC的发生中起重要作用。此外,只有1例肿瘤在3p和5q上均表现出LOH,这表明LOH并非顺序发生而是独立发生的。

相似文献

1
Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.肾细胞癌中3号染色体短臂、5号染色体长臂和17号染色体短臂的等位基因缺失。
Pathol Int. 1997 Feb-Mar;47(2-3):79-83. doi: 10.1111/j.1440-1827.1997.tb03724.x.
2
Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).探讨散发性肾透明细胞癌(cRCC)中除 VHL 以外的 3p 缺失肿瘤抑制基因。
Urol Oncol. 2013 Oct;31(7):1333-42. doi: 10.1016/j.urolonc.2011.08.012. Epub 2011 Oct 1.
3
Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.肾细胞癌中的基因组改变与不稳定性及其与肿瘤病理学的关系。
Cancer Res. 1995 Dec 15;55(24):6189-95.
4
Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.散发性肾细胞癌中的基因改变:对包含3p、5q和17p染色体区域的肿瘤抑制基因的分子分析。
World J Urol. 1994;12(3):162-8. doi: 10.1007/BF00192279.
5
Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.人类肾细胞癌中17号染色体短臂的等位基因缺失与3号染色体短臂的等位基因缺失呈负相关。
Cancer Res. 1992 Apr 1;52(7):1881-5.
6
Genetic analysis of synchronous mucinous tumors of the ovary and appendix.卵巢和阑尾同步性黏液性肿瘤的基因分析
Hum Pathol. 1996 Feb;27(2):165-71. doi: 10.1016/s0046-8177(96)90370-6.
7
Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.散发性肾细胞癌的分子遗传学研究:3p、5q、11p、17和22号染色体上等位基因缺失的分析
Br J Cancer. 1994 Feb;69(2):230-4. doi: 10.1038/bjc.1994.44.
8
Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.等位基因缺失分数数据表明非小细胞肺癌发展过程中存在不同的基因群体。
Br J Cancer. 1996 Dec;74(12):1968-74. doi: 10.1038/bjc.1996.661.
9
Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.多发性高级别支气管发育异常和鳞状细胞癌:一致和不一致的突变
Clin Cancer Res. 2001 Feb;7(2):259-66.
10
Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.在3号染色体短臂和17号染色体短臂上频繁出现杂合性缺失,且无VHL或p53突变,这表明未明确的肿瘤抑制基因参与了滤泡性甲状腺癌的发生。
J Clin Endocrinol Metab. 1997 Nov;82(11):3684-91. doi: 10.1210/jcem.82.11.4352.

引用本文的文献

1
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.IRF-1 抑制 HPV16 E6 癌蛋白在宫颈癌中的血管生成活性。
Int J Mol Sci. 2020 Oct 15;21(20):7622. doi: 10.3390/ijms21207622.
2
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.17p13 号染色体缺失与肾透明细胞癌侵袭性肿瘤表型相关。
World J Surg Oncol. 2020 Jun 13;18(1):128. doi: 10.1186/s12957-020-01902-y.
3
Interferon regulatory factor 1 inactivation in human cancer.干扰素调节因子 1 在人类癌症中的失活。
Biosci Rep. 2018 May 8;38(3). doi: 10.1042/BSR20171672. Print 2018 Jun 29.
4
Novel IRF-1 Mutations in a Small Cohort of Leukaemia Patients From Saudi Arabia.沙特阿拉伯一小群白血病患者中的新型IRF-1突变
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2795-2801. doi: 10.22034/APJCP.2017.18.10.2795.
5
Establishment and characterization of a highly immunogenic human renal carcinoma cell line.一种高免疫原性人肾癌细胞系的建立与鉴定
Int J Oncol. 2016 Aug;49(2):457-70. doi: 10.3892/ijo.2016.3544. Epub 2016 May 27.
6
Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines.扁平型和息肉样结肠炎相关结直肠肿瘤对化学预防剂和杂环胺的差异反应。
Cancer Lett. 2013 Jun 28;334(1):62-8. doi: 10.1016/j.canlet.2013.02.013. Epub 2013 Feb 13.
7
IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation.干扰素调节因子1通过干扰Sp1激活来抑制Ki-67启动子活性。
Tumour Biol. 2012 Dec;33(6):2217-25. doi: 10.1007/s13277-012-0483-3. Epub 2012 Aug 14.